Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOENSIS is a private life science services company focused on predictive pharmacology and preclinical drug evaluation. The company offers 2D and 3D cellular pharmacology services designed to better replicate human tissue and tumor microenvironments than conventional in vitro assays. Its platform is used to assess small molecules, biologics, therapeutic antibodies, and oncolytic viruses across tumor-derived cell lines and primary tissue systems. BIOENSIS appears to operate primarily as a contract research organization supporting oncology-focused discovery and translational research rather than as a clinical-stage therapeutic developer. The company is based in Bothell, Washington and markets customized assay services intended to improve early-stage drug development decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOENSIS.